Skip to main content
SpringerLink
Log in
Book cover

Anticancer Genes pp 213–227Cite as

Isolation and Characterization of the Anticancer Gene Organic Cation Transporter Like-3 (ORCTL3)

  • Chapter
  • First Online:

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 818))

Abstract

ORCTL3, an organic cation/anion transporter expressed in various tissue types, was isolated in a genome-wide cDNA screen as a gene with a tumor-specific apoptosis activity. When overexpressed it elicits an apoptosis response in many transformed cells, while normal cells remain unaffected. It can be activated for apoptosis induction by individual tumorigenic mutations in renal cells. This effect is independent of the tumor cells’ proliferation status and mediated by an incomplete ER stress response, characterized by the accumulation of the endoplasmic reticulum-stress marker ATF4, but not BiP. Recent studies show that for its apoptosis induction activity ORCTL3 targets the enzyme stearoyl-CoA desaturase-1 (SCD-1) that is involved in the fatty acid metabolism. This is evidenced by the inhibition of apoptosis induced through ORCTL3 when the SCD-1 product oleic acid is exogenously supplemented or when SCD-1 is co-transfected in the transformed cells. ORCTL3’s activity to specifically target tumor cells is caused by the transmembrane domains 3 and 4 of the mouse, but not the human, gene. In an in vivo model ORCTL3 shows a significant shrinkage in the size of xenograft tumors when injected with an adenoviral carrier carrying the mouse ORCTL3 gene. An ex vivo study using human renal cancer cells confirmed the promising tumor-specific apoptosis effect of ORCTL3. Since ORCTL3 targets fatty acid metabolism in transformed cells and induces an ER stress specifically in these cells, it reveals a novel therapeutic interference option for tumor cells.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Murata Y, Tamari M, Takahashi T, Horio Y, Hibi K, Yokoyama S, Inazawa J, Yamakawa K, Ogawa A, Takahashi T, Nakamura Y (1994) Characterization of an 800-kb region at 3p22p21.3 that was homozygously deleted in a lung cancer cell line. Hum Mol Genet 3:1341–1344

    Article  CAS  PubMed  Google Scholar 

  2. Nishiwaki T, Daigo Y, Tamari M, Fujii Y, Nakamura Y (1998) Molecular cloning, mapping, and characterization of two novel human genes, ORCTL3 and ORCTL4, bearing homology to organic-cation transporters. Cytogenet Cell Genet 83:251–255

    Article  CAS  PubMed  Google Scholar 

  3. Lee WK, Hwang JS, Yun CH, Cha SH (2007) Identification of a kidney-specific mouse organic cation transporter like-1 (mOCTL1). Exp Mol Med 39(6):787–795

    Article  CAS  PubMed  Google Scholar 

  4. Bahn A, Hagos Y, Reuter S, Balen D, Brzica H, Krick W, Burckhardt BC, Sabolic I, Burckhardt G (2008) Identification of a new urate and high affinity nicotinate transporter, hOAT10 (SLC22A13). J Biol Chem 283(24):16332–16341

    Article  CAS  PubMed  Google Scholar 

  5. Kyte J, Doolittle RF (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157:105–132

    Article  CAS  PubMed  Google Scholar 

  6. Hara N, Yamada K, Shibata T, Osago H, Hashimoto T, Tsuchiya M (2007) Elevation of cellular NAD levels by nicotinic acid and involvement of nicotinic acid phosphoribosyltransferase in human cells. J Biol Chem 282:24574–24582

    Article  CAS  PubMed  Google Scholar 

  7. Irshad S, Mahul-Mellier AL, Kassouf N, Lemarie A, Grimm S (2009) Isolation of ORCTL3 in a novel genetic screen for tumor-specific apoptosis inducers. Cell Death Differ 16(6):890–898

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Numa F, Hirabayashi K, Tsunaga N, Kato H, ORourke K, Shao H, Stechmann-Lebakken C, Varani J, Rapraeger A, Dixit VM (1995) Elevated levels of syndecan-1 expression confer potent serum-dependent growth in human 293t cells. Cancer Res 55(20):4676–4680

    CAS  PubMed  Google Scholar 

  9. Dalgliesh GL et al (2010) Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 463:360–363. doi:10.1038/nature08672

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Gerlinger M et al (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366:883–892. doi:10.1056/NEJMoa1113205

    Article  CAS  PubMed  Google Scholar 

  11. AbuAli G, Stelloo E, Chaisaklert W, Pazarentzos E, Hwang MS, Aboagye EO, Grimm S. The anticancer gene ORCTL3 targets stearoyl- CoA desaturase-1 for tumour-specific apoptosis. Oncogene, advance online publication 28 April 2014. doi:10.1038/onc.2014.93

  12. Minville-Walz M, Pierre AS, Pichon L, Bellenger S, Fevre C, Bellenger J, Tessier C, Narce M, Rialland M (2010) Inhibition of stearoyl-coA desaturase 1 expression induces CHOP-dependent cell death in human cancer cells. PLoS One 12(5):e14363

    Article  Google Scholar 

  13. Masuda M, Ting TC, Levi M, Saunders SJ, Miyazaki-Anzai S, Miyazaki M (2012) Activating transcription factor 4 regulates stearate-induced vascular calcification. J Lipid Res 53(8):1543–1552

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Enoch HG, Catal A, Strittmatter P (1976) Mechanism of rat liver microsomal stearyl-coA desaturase. Studies of the substrate specificity, enzyme-substrate interactions, and the function of lipid. J Biol Chem 251(16):5095–5103

    CAS  PubMed  Google Scholar 

  15. Popeijus HE, Saris WH, Mensink RP (2008) Role of stearoyl-coA desaturases in obesity and the metabolic syndrome. Int J Obes (Lond) 32(7):1076–1082

    Article  CAS  Google Scholar 

  16. Scaglia N, Chisholm JW, Igal RA (2009) Inhibition of stearoyl coA desaturase-1 inactivates acetyl-coA carboxylase and impairs proliferation in cancer cells: role of AMPK. PLoS One 8(4):e6812

    Article  Google Scholar 

  17. Kumar-Sinha C, Ignatoski KW, Lippman ME, Ethier SP, Chinnaiyan AM (2003) Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. Cancer Res 63(1):132–139

    CAS  PubMed  Google Scholar 

  18. Scaglia N, Igal RA (2005) Stearoyl-coA desaturase is involved in the control of proliferation, anchorage-independent growth, and survival in human transformed cells. J Biol Chem 280:25339–25349

    Article  CAS  PubMed  Google Scholar 

  19. Swinnen JV, Vanderhoydonc F, Elgamal AA, Eelen M, Vercaeren I, Joniau S, Van Poppel H, Baert L, Goossens K, Heyns W, Verhoeven G (2000) Selective activation of the fatty acid synthesis pathway in human prostate cancer. Int J Cancer 2(2):176–179

    Article  Google Scholar 

  20. Morgan-Lappe SE, Tucker LA, Huang X, Zhang Q, Sarthy AV, Zakula D, Vernetti L, Schurdak M, Wang J, Fesik SW (2007) Identification of ras-related nuclear protein, targeting protein for xenopus kinesin-like protein 2, and stearoyl-coA desaturase 1 as promising cancer targets from an RNAi-based screen. Cancer Res 67(9):4390–4398

    Article  CAS  PubMed  Google Scholar 

  21. Warburg O (1930) The metabolism of tumours. Arnold Constable, London

    Google Scholar 

  22. Cairns RA, Harris IS, Mak TW (2011) Regulation of cancer cell metabolism. Nat Rev Cancer 11:85–95

    Article  CAS  PubMed  Google Scholar 

  23. Mason P, Liang B, Li L, Fremgen T, Murphy E, Quinn A, Madden SL, Biemann HP, Wang B, Cohen A, Komarnitsky S, Jancsics K, Hirth B, Cooper CGF, Lee E, Wilson S, Krumbholz R, Schmid S, Xiang Y, Booker M, Lillie J, Carter K (2012) SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acids. PLoS One 7(3):e33823

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Li J, Ding SF, Habib NA, Fermor BF, Wood CB, Gilmour RS (1994) Partial characterization of a cdna for human stearoyl-coA desaturase and changes in its mRNA expression in some normal and malignant tissues. Int J Cancer 57(3):348–352

    Article  CAS  PubMed  Google Scholar 

  25. Breuer S, Pech K, Buss A, Spitzer C, Ozols J, Hol EM, Heussen N, Noth J, Schwaiger FW, Schmitt AB (2004) Regulation of stearoyl-coA desaturase-1 after central and peripheral nerve lesions. BMC Neurosci 5:15

    Article  PubMed Central  PubMed  Google Scholar 

  26. Wang J, Yu L, Schmidt RE, Su C, Huang X, Gould K, Cao G (2005) Characterization of HSCD5, a novel human stearoyl-coA desaturase unique to primates. Biochem Biophys Res Commun 332(3):735–742

    Article  CAS  PubMed  Google Scholar 

  27. Brown JM, Rudel LL (2010) Stearoyl-coenzyme a desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery. Curr Opin Lipidol 21(3):192–197

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Over-weight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638

    Article  PubMed  Google Scholar 

  29. Ceschi M, Gutzwiller F, Moch H, Eichholzer M, Probst-Hensch NM (2007) Epidemiology and pathophysiology of obesity as cause of cancer. Swiss Med Wkly 137:50–56

    CAS  PubMed  Google Scholar 

  30. Gong Z, Agalliu I, Lin DW, Stanford JL, Kristal AR (2007) Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men. Cancer 109:1192–1202

    Article  PubMed  Google Scholar 

  31. Igal RA (2010) Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer. Carcinogenesis 31(9):1509–1515

    Article  CAS  PubMed  Google Scholar 

  32. Iwasawa R, Mahul-Mellier AL, Datler C, Pazarentzos E, Grimm S (2011) Fis1 and bap31 bridge the mitochondria-ER interface to establish a platform for apoptosis induction. EMBO J 30:556–568

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  33. Temel RE, Rudel LL (2007) Diet effects on atherosclerosis in mice. Curr Drug Targets 8:1150–1160

    Article  CAS  PubMed  Google Scholar 

  34. Lupi R, Dotta F, Marselli L, Del Guerra S, Masini M, Santangelo C, Patan G, Boggi U, Piro S, Anello M, Bergamini E, Mosca F, Di Mario U, Del Prato S, Marchetti P (2002) Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 51(5):1437–1442

    Article  CAS  PubMed  Google Scholar 

  35. Shimabukuro M, Zhou YT, Levi M, Unger RH (1998) Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci U S A 95(5):2498–2502

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  36. Maedler K, Oberholzer J, Bucher P, Spinas GA, Donath MY (2003) Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes 52(3):726–733

    Article  CAS  PubMed  Google Scholar 

  37. Kaelin WG Jr (2005) The concept of synthetic lethality in the context of anticancer therapy. Nat Rev Cancer 5:689–698

    Article  CAS  PubMed  Google Scholar 

  38. Maestre I, Jordn J, Calvo S, Reig JA, Cea V, Soria B, Prentki M, Roche E (2003) Mitochondrial dysfunction is involved in apoptosis induced by serum withdrawal and fatty acids in the beta-cell line INS-1. Endocrinology 144(1):335–345

    Article  CAS  PubMed  Google Scholar 

  39. El-Assaad W, Buteau J, Peyot ML, Nolan C, Roduit R, Hardy S, Joly E, Dbaibo G, Rosenberg L, Prentki M (2003) Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinology 144(9):4154–4163

    Article  CAS  PubMed  Google Scholar 

  40. Busch AK, Gurisik E, Cordery DV, Sudlow M, Denyer GS, Laybutt DR, Hughes WE, Biden TJ (2005) Increased fatty acid desaturation and enhanced expression of stearoyl coenzyme a desaturase protects pancreatic beta-cells from lipoapoptosis. Diabetes 54(10):2917–2924

    Article  CAS  PubMed  Google Scholar 

  41. Gentile CL, Pagliassotti MJ (2008) The role of fatty acids in the development and progression of nonalcoholic fatty liver disease. J Nutr Biochem 19(9):567–576

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Pickens MK, Yan JS, Ng RK, Ogata H, Grenert JP, Beysen C, Turner SM, Maher JJ (2009) Dietary sucrose is essential to the development of liver injury in the methionine-choline-deficient model of steatohepatitis. J Lipid Res 50(10):2072–2082

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  43. Esteve M, Navarro E, Klaassen J, Abad-Lacruz A, Gonzlez-Huix F, Cabr E, Ramos E, Condom E, Fernndez-Baares F, Pastor C, Humbert P, Mart-Ragu J, Gassull MA (1998) Plasma and mucosal fatty acid pattern in colectomized ulcerative colitis patients. Dig Dis Sci 43(5):1071–1078

    Article  CAS  PubMed  Google Scholar 

  44. Ji Z, Mei FC, Lory PL, Gilbertson SR, Chen Y, Cheng X (2009) Chemical genetic screening of KRAS-based synthetic lethal inhibitors for pancreatic cancer. Front Biosci 14:2904–2910

    Article  CAS  Google Scholar 

  45. Ferrari E, Lucca C, Foiani M (2010) A lethal combination for cancer cells: synthetic lethality screenings for drug discovery. Eur J Cancer 46:2889–2895

    Article  PubMed  Google Scholar 

  46. Kamimura K, Suda T, Zhang G, Liu G (2011) Advances in gene delivery systems. Pharm Med 25(5):293–306

    Article  Google Scholar 

  47. Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M, Shearer G, Chang L, Chiang Y, Tolstoshev P, Greenblatt JJ, Rosenberg SA, Klein H, Berger M, Mullen CA, Ramsey WJ, Muul L, Morgan RA, Anderson WF (1995) T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science 475–80(5235):270

    Google Scholar 

  48. Kim FJ, Campagna A, Khandrika L, Koul S, Byun SS, vanBokhoven A, Moore EE, Koul H (2008) Individualized medicine for renal cell carcinoma: establishment of primary cell line culture from surgical specimens. J Endourol 22(10):2361–2366

    Article  PubMed Central  PubMed  Google Scholar 

  49. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277–300

    Article  PubMed  Google Scholar 

  50. Valente MJ, Henrique R, Costa VL, Jeronimo C, Carvalho F, Bastos ML, de Pinho PG, Carvalho M (2011) A rapid and simple procedure for the establishment of human normal and cancer renal primary cell cultures from surgical specimens. PLoS One 6(5):e19337

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  51. Pittoggi C, Martis G, Mastrangeli G, Mastrangeli B, Spadafora C (2008) In vitro evidence for a new therapeutic approach in renal cell carcinoma. Int Braz J Urol 34(4):492–502

    Article  PubMed  Google Scholar 

  52. Moore S, Knudsen B, True LD, Hawley S, Etzioni R, Wade C, Gifford D, Coleman I, Nelson PS (2005) Loss of stearoyl-coA desaturase expression is a frequent event in prostate carcinoma. Int J Cancer 144(4):563–571

    Article  Google Scholar 

  53. Piro S, Anello M, Di Pietro C, Lizzio MN, Patan G, Rabuazzo AM, Vigneri R, Purrello M, Purrello F (2002) Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress. Metabolism 51(10):1340–1347

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Experimental Medicine, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN, UK

    Ghada AbuAli & Stefan Grimm

Authors
  1. Ghada AbuAli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stefan Grimm
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hammersmith Campus, Imperial College London, London, United Kingdom

    Stefan Grimm

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

AbuAli, G., Grimm, S. (2014). Isolation and Characterization of the Anticancer Gene Organic Cation Transporter Like-3 (ORCTL3). In: Grimm, S. (eds) Anticancer Genes. Advances in Experimental Medicine and Biology, vol 818. Springer, London. https://doi.org/10.1007/978-1-4471-6458-6_11

Download citation

Publish with us

Policies and ethics

Search

Navigation